Prior Auth Required

02210 - 6 Casgevy prescribing information, Vertex Pharmaceuticals Incorporated, Boston, MA . Revised 9/2025 Oct 2025

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Service6 Casgevy prescribing information, Vertex Pharmaceuticals Incorporated, Boston, MA . Revised 9/2025 Oct 2025
Procedure / Service Description

Pharmacy Policy - 5 Institute for Clinical and Economic Review (ICER). ICER Sickle Cell Disease Final Report. Published August 21, 2023. Nov Available at: https://icer.org/wp-content/uploads/2023/08/ICER_SCD_Final_Report_FOR_PUBLICATION_082123.pdf 2023 6 Casgevy prescribing information, Vertex Pharmaceuticals Incorporated, Boston, MA 02210. Revised 9/2025 Oct 2025 7 Casgevy (exagamglogene autotemcel) clinical trial (NCT03655678). Available at: Feb https://clinicaltrials.gov/study/NCT03655678?cond=NCT03655678&rank=1 2024

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.